Spiriva Respimat (Tiotropium bromide) for asthma | MyAsthmaTeam

Connect with others who understand.

sign up Log in
About MyAsthmaTeam
Powered By

Spiriva Respimat is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat asthma in people aged 12 years and older. Spiriva is also referred to by its drug name, tiotropium bromide.

Spiriva Respimat is a member of a class of drugs called anticholinergic bronchodilators, which dilate the airways in the lungs, making it easier to breathe. Spiriva Respimat is believed to work by binding to cholinergic nerve receptors in the airways, which causes the smooth muscle of the airways to relax and dilate.

How do I take it?
Prescribing information states that Spiriva Respimat is administered once daily through an aerosol inhaler.

Spiriva Respimat should be taken exactly as prescribed by a physician.

Side effects
The FDA-approved label for Spiriva Respimat lists common side effects including sore throat, sinus infection, bronchitis, and headache.

Rare but serious side effects listed for Spiriva Respimat include severe allergic reactions, worsening of existing glaucoma or urinary retention, and paradoxical bronchospasm (airway smooth muscle spasm caused by medication).

For more details about this treatment, visit:

Spiriva Respimat — Boehringer Ingelheim

Tiotropium (Inhalation Route) — Mayo Clinic

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in